Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vanda Pharmaceuticals (VNDA) Interest & Investment Income: 2010-2011

Historic Interest & Investment Income for Vanda Pharmaceuticals (VNDA) over the last 2 years, with Dec 2011 value amounting to $99,000.

  • Vanda Pharmaceuticals' Interest & Investment Income fell 30.28% to $99,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $482,000, marking a year-over-year change of. This contributed to the annual value of $461,000 for FY2011, which is 6.96% up from last year.
  • According to the latest figures from Q4 2011, Vanda Pharmaceuticals' Interest & Investment Income is $99,000, which was down 6.60% from $106,000 recorded in Q3 2011.
  • Over the past 5 years, Vanda Pharmaceuticals' Interest & Investment Income peaked at $156,000 during Q3 2010, and registered a low of $47,000 during Q2 2010.
  • Its 2-year average for Interest & Investment Income is $114,167, with a median of $120,500 in 2011.
  • Data for Vanda Pharmaceuticals' Interest & Investment Income shows a peak YoY increase of 187.23% (in 2011) and a maximum YoY decrease of 32.05% (in 2011) over the last 5 years.
  • Vanda Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $142,000 in 2010, then tumbled by 30.28% to $99,000 in 2011.
  • Its last three reported values are $99,000 in Q4 2011, $106,000 for Q3 2011, and $135,000 during Q2 2011.